Cargando…
Estimated costs for Duchenne muscular dystrophy care in Brazil
BACKGROUND: The economic burden of rare diseases on health systems is still not widely measured, with the generation of accurate information about the costs with medical care for subjects with rare diseases being crucial when defining health policies. Duchenne Muscular Dystrophy (DMD) is the most co...
Autores principales: | Schneider, Nayê Balzan, Roos, Erica Caetano, Staub, Ana Lúcia Portella, Bevilacqua, Isabela Possebon, de Almeida, Ana Carolina, de Camargo Martins, Tamiê, Ramos, Natalia Bergamelli, Loze, Priscilla, Saute, Jonas Alex Morales, Etges, Ana Paula Beck da Silva, Polanczyk, Carisi Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288739/ https://www.ncbi.nlm.nih.gov/pubmed/37349725 http://dx.doi.org/10.1186/s13023-023-02767-6 |
Ejemplares similares
-
Update of the Brazilian consensus recommendations on Duchenne muscular dystrophy
por: Araujo, Alexandra Prufer de Queiroz Campos, et al.
Publicado: (2023) -
A standardized framework to evaluate the quality of studies using TDABC in healthcare: the TDABC in Healthcare Consortium Consensus Statement
por: Etges, Ana Paula Beck da Silva, et al.
Publicado: (2020) -
Value-based Reimbursement as a Mechanism to Achieve Social and Financial Impact in the Healthcare System
por: de Silva Etges, Ana Paula Beck, et al.
Publicado: (2023) -
Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012) -
Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021)